默沙东引入Isomorphic Labs AI模型加速肿瘤靶点小分子药物发现
STAT+: Lawmakers want U.S. biotech to outcompete China
默沙东已选定一个具有战略重要性的肿瘤靶点,并携自有湿实验数据引入Isomorphic Labs合作,探索是否可利用DeepMind衍生公司的AI模型更快找到有前景的小分子候选药物。默沙东在该靶点上已有相关研究积累,此次合作旨在借助人工智能提升早期药物发现效率。
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
With Heidi Overton out, who’s gonna lead the FDA? We should endeavor a guess, March Madness-style. STAT Madness, regulatory edition.
Merck enlists Isomorphic for mystery target
Merck already has an oncology target it considers strategically important — and a trove of wet lab data from its own work on it. Now, STAT’s Katherine MacPhail writes exclusively, it’s bringing in Isomorphic Labs to see whether the DeepMind spinoff’s AI models can use those data to find promising small molecules faster.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT 主站 · statnews.com